737 related articles for article (PubMed ID: 20189638)
21. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
Spire B; Lucas GM; Carrieri MP
Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
[TBL] [Abstract][Full Text] [Related]
22. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Addiction; 2018 Mar; 113(3):545-563. PubMed ID: 28891267
[TBL] [Abstract][Full Text] [Related]
23. Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modeling.
Vickerman P; Platt L; Jolley E; Rhodes T; Kazatchkine MD; Latypov A
Int J Drug Policy; 2014 Nov; 25(6):1163-73. PubMed ID: 25449056
[TBL] [Abstract][Full Text] [Related]
24. Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us?
Mathers BM; Degenhardt L; Adam P; Toskin I; Nashkhoev M; Lyerla R; Rugg D
J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S132-42. PubMed ID: 19901626
[TBL] [Abstract][Full Text] [Related]
25. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
Lurie P; Jones TS; Foley J
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
[TBL] [Abstract][Full Text] [Related]
26. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.
Stark K; Müller R; Bienzle U; Guggenmoos-Holzmann I
J Epidemiol Community Health; 1996 Oct; 50(5):534-7. PubMed ID: 8944860
[TBL] [Abstract][Full Text] [Related]
27. The role of needle exchange programs in HIV prevention.
Vlahov D; Junge B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
[TBL] [Abstract][Full Text] [Related]
28. Optimal provision of needle and syringe programmes for injecting drug users: A systematic review.
Jones L; Pickering L; Sumnall H; McVeigh J; Bellis MA
Int J Drug Policy; 2010 Sep; 21(5):335-42. PubMed ID: 20189375
[TBL] [Abstract][Full Text] [Related]
29. HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications.
Bruce RD; Dvoryak S; Sylla L; Altice FL
Int J Drug Policy; 2007 Aug; 18(4):326-8. PubMed ID: 17689382
[TBL] [Abstract][Full Text] [Related]
30. The cost-effectiveness of harm reduction.
Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
[TBL] [Abstract][Full Text] [Related]
31. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
32. Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview.
Bobrova N; Sarang A; Stuikyte R; Lezhentsev K
Int J Drug Policy; 2007 Aug; 18(4):313-8. PubMed ID: 17689380
[TBL] [Abstract][Full Text] [Related]
33. Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis.
Hines LA; Trickey A; Leung J; Larney S; Peacock A; Degenhardt L; Colledge S; Hickman M; Grebely J; Cunningham EB; Stone J; Dumchev K; Griffiths P; Vickerman P; Mattick RP; Lynskey M
Lancet Glob Health; 2020 Jan; 8(1):e76-e91. PubMed ID: 31839143
[TBL] [Abstract][Full Text] [Related]
34. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
Turner KM; Hutchinson S; Vickerman P; Hope V; Craine N; Palmateer N; May M; Taylor A; De Angelis D; Cameron S; Parry J; Lyons M; Goldberg D; Allen E; Hickman M
Addiction; 2011 Nov; 106(11):1978-88. PubMed ID: 21615585
[TBL] [Abstract][Full Text] [Related]
35. Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020.
Tookes HE; Bartholomew TS; Sugar SES; Plesons MD; Bluthenthal RN; Wenger LD; Patel SV; Kral AH; Lambdin BH
Int J Drug Policy; 2024 Jan; 123():104289. PubMed ID: 38071932
[TBL] [Abstract][Full Text] [Related]
36. Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review.
Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J
Lancet Glob Health; 2023 Dec; 11(12):e1885-e1898. PubMed ID: 37973339
[TBL] [Abstract][Full Text] [Related]
37. Implementation of harm reduction in Central and Eastern Europe and Central Asia.
Sarang A; Stuikyte R; Bykov R
Int J Drug Policy; 2007 Mar; 18(2):129-35. PubMed ID: 17689355
[TBL] [Abstract][Full Text] [Related]
38. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
Panda S; Sharma M
Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
[TBL] [Abstract][Full Text] [Related]
39. Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange.
Heimer R
Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S65-73. PubMed ID: 18207726
[TBL] [Abstract][Full Text] [Related]
40. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.
Low AJ; Mburu G; Welton NJ; May MT; Davies CF; French C; Turner KM; Looker KJ; Christensen H; McLean S; Rhodes T; Platt L; Hickman M; Guise A; Vickerman P
Clin Infect Dis; 2016 Oct; 63(8):1094-1104. PubMed ID: 27343545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
